Epigenetic Regulation of BDNF in Schizophrenia

NCT01021449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2013-09-12

No results posted yet for this study

Summary

In this proposal, we will (1) detect the associations between BDNF and Trk B gene DNA methylation, histone modification, psychotic symptoms, obesity, suicide and antipsychotic drug responses in Taiwanese patients (2) discuss the possible mechanisms of epigenetic regulation of BDNF and Trk B in schizophrenia patients.

Conditions

  • BDNF, DNA Methylation, Suicide, Drug Responses.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Tiao-Lai Huang, M.D. · Chang-Gung Memorial Hospital, Kaohsiung

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01021449 on ClinicalTrials.gov